> top > docs > PubMed:26215578 > spans > 0-350 > annotations

PubMed:26215578 / 0-350 JSONTXT

Annnotations TAB JSON ListView MergeView

c_corpus

Id Subject Object Predicate Lexical cue
T1 0-10 D066260 denotes Epiregulin
T2 0-10 D066260 denotes Epiregulin
T3 26-32 UBERON:0000310 denotes breast
T4 33-46 D063646 denotes tumorigenesis
T5 33-46 D063646 denotes tumorigenesis
T6 66-72 UBERON:0027368 denotes matrix
T8 66-92 Q11133 denotes matrix metalloproteinase 1
T10 66-92 P21692 denotes matrix metalloproteinase 1
T11 66-92 P81563 denotes matrix metalloproteinase 1
T12 66-92 Q8GWW6 denotes matrix metalloproteinase 1
T14 66-92 PR:000010469 denotes matrix metalloproteinase 1
T15 66-92 Q9XSZ5 denotes matrix metalloproteinase 1
T16 66-92 P28053 denotes matrix metalloproteinase 1
T17 66-92 P13943 denotes matrix metalloproteinase 1
T18 66-92 P03956 denotes matrix metalloproteinase 1
T13 66-92 D020781 denotes matrix metalloproteinase 1
T7 66-92 GO:0004232 denotes matrix metalloproteinase 1
T9 66-92 GO:0051405 denotes matrix metalloproteinase 1
T20 138-154 UBERON:0000021 denotes epidermal growth
T23 138-161 Q9GU69 denotes epidermal growth factor
T21 138-161 D004815 denotes epidermal growth factor
T22 138-161 D004815 denotes epidermal growth factor
T24 138-161 GO:0005154 denotes epidermal growth factor
T30 163-166 Q95ND4 denotes EGF
T32 163-166 PR:P01133 denotes EGF
T33 163-166 P01133 denotes EGF
T34 163-166 PR:P07522 denotes EGF
T35 163-166 PR:P01132 denotes EGF
T36 163-166 Q9BEA0 denotes EGF
T37 163-166 P01132 denotes EGF
T38 163-166 P07522 denotes EGF
T40 163-166 PR:000006928 denotes EGF
T41 163-166 P26224 denotes EGF
T43 163-166 Q00968 denotes EGF
T31 163-166 CHEBI:140739 denotes EGF
T42 163-166 D004815 denotes EGF
T44 163-166 D004815 denotes EGF
T39 163-166 GO:0005154 denotes EGF
T45 178-185 CHEBI:52214 denotes ligands
T46 219-225 UBERON:0000310 denotes breast
T47 219-232 D001943 denotes breast cancer
T48 219-232 D001943 denotes breast cancer
T49 290-293 Q95ND4 denotes EGF
T51 290-293 PR:P01133 denotes EGF
T52 290-293 P01133 denotes EGF
T53 290-293 PR:P07522 denotes EGF
T54 290-293 PR:P01132 denotes EGF
T55 290-293 Q9BEA0 denotes EGF
T56 290-293 P01132 denotes EGF
T57 290-293 P07522 denotes EGF
T59 290-293 PR:000006928 denotes EGF
T60 290-293 P26224 denotes EGF
T62 290-293 Q00968 denotes EGF
T50 290-293 CHEBI:140739 denotes EGF
T61 290-293 D004815 denotes EGF
T63 290-293 D004815 denotes EGF
T58 290-293 GO:0005154 denotes EGF
T64 301-308 CHEBI:52214 denotes ligands
T65 332-338 UBERON:0000310 denotes breast
T66 332-345 D001943 denotes breast cancer
T67 332-345 D001943 denotes breast cancer

UseCases_ArguminSci_Discourse

Id Subject Object Predicate Lexical cue
T1 0-121 DRI_Background denotes Epiregulin contributes to breast tumorigenesis through regulating matrix metalloproteinase 1 and promoting cell survival.
T2 134-268 DRI_Outcome denotes The epidermal growth factor (EGF) family of ligands has been implicated in promoting breast cancer initiation, growth and progression.

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
26215578-0#0#10#gene2069 163-306 gene2069 denotes EGF) family of ligands has been implicated in promoting breast cancer initiation, growth and progression. The contributions of EGF family ligan
26215578-2#21#24#gene1950 290-293 gene1950 denotes EGF
26215578-2#21#24#gene1950 290-293 gene1950 denotes EGF
26215578-2#63#76#diseaseC0006142 332-345 diseaseC0006142 denotes breast cancer
26215578-2#63#76#diseaseC0678222 332-345 diseaseC0678222 denotes breast cancer
21#24#gene195063#76#diseaseC0006142 26215578-2#21#24#gene1950 26215578-2#63#76#diseaseC0006142 associated_with EGF,breast cancer
21#24#gene195063#76#diseaseC0678222 26215578-2#21#24#gene1950 26215578-2#63#76#diseaseC0678222 associated_with EGF,breast cancer
21#24#gene195063#76#diseaseC0006142 26215578-2#21#24#gene1950 26215578-2#63#76#diseaseC0006142 associated_with EGF,breast cancer
21#24#gene195063#76#diseaseC0678222 26215578-2#21#24#gene1950 26215578-2#63#76#diseaseC0678222 associated_with EGF,breast cancer